Effect of Percutaneous Needle Electrolysis (PNE) on Tendinopathy

Last updated: November 19, 2025
Sponsor: Universidad Rey Juan Carlos
Overall Status: Completed

Phase

N/A

Condition

Sprains

Tendon Injuries

Treatment

Percutaneous needle electrolysis

Manual therapy

Therapeutic exercise

Clinical Study ID

NCT05370092
1801202201622
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to test the efficacy of percutaneous electrolysis in posterior tibial tendinopathies. The posterior tibial tendon injury is one of the most frequent pathologies in the lower extremities, and therefore a correct study and evaluation of it is necessary. This study aims to compare the therapeutic effect of percutaneous electrolysis comparing a control group with an experimental group. To evaluate functionality, pain and its ultrasound pattern before and after treatment, in order to assess the efficacy of the treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects over 18 years of age

  • Mild inflammation, swelling and/or tenderness posterior to the medial malleolus

  • Pain posterior and/or superior to the medial malleolus, aggravated by activity

  • Pain present for at least 3 months

  • One or more signs of flexible flatfoot deformity, including excessive valgusdeformity of the hindfoot during weight bearing and/or excessive foot abduction (many toes sign).

  • Pain when performing the Hell Rise Test or performed incorrectly.

  • Signs of tenosynovitis on ultrasound examination.

As the inclusion criteria are based on side-to-side comparison all participants had to have unilateral involvement.

Exclusion

Exclusion Criteria:

  • Previous surgery on the affected foot, leg or knee.

  • Disabling osteoarthritis of the knee on the affected side.

  • Fixed hindfoot deformities.

  • Recurrent ankle sprains on the affected side.

  • Ligament tears or bony abnormalities of the affected foot.

  • A physical or medical condition that contraindicates the testing protocol.

  • Pregnancy.

  • FCD or FLH tendinopathy.

Study Design

Total Participants: 46
Treatment Group(s): 3
Primary Treatment: Percutaneous needle electrolysis
Phase:
Study Start date:
March 20, 2022
Estimated Completion Date:
June 30, 2025

Study Description

A single-blind, longitudinal, randomised, controlled, single-blind, longitudinal, randomised, controlled clinical trial will be conducted. First, the participant will receive a FOOT AND ANKLE ABILITY (FAAM) survey, along with a numerical pain scale, both of which must be completed. Next, an ultrasound study of the foot will be performed, focusing on pain in the inner ankle, to check for possible pathology in the posterior tibial tendon. Finally, the physiotherapist's intervention will be carried out to check the effectiveness of the technique, which may cause some pain, and finally, the numerical pain scale will be passed again. Four sessions will be carried out in four different weeks, always using the same day of the week for the intervention and following the same steps as above. The purpose of this study is to test the efficacy of PD in posterior tibial tendinopathy and whether PD is therefore a safe technique for this type of intervention. All patients will sign an informed consent form and will be informed about the study beforehand.

Connect with a study center

  • Universidad Rey Juan Carlos

    Madrid 3117735, Madrid 3117732 28933
    Spain

    Site Not Available

  • Universidad Rey Juan Carlos

    Madrid, 28933
    Spain

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.